The TJX Companies, Inc. (TJX) is likely to register top-line growth when it reports first-quarter fiscal 2026 earnings on May 21. The Zacks Consensus Estimate for quarterly revenues is pegged at almost $13 billion, which indicates a 4% increase from the year-ago quarter’s reported figure.Nevertheless, The TJX Companies is expected to witness a year-over-year decrease in its bottom line. The Zacks Consensus Estimate, which has been stable over the past 30 days at 90 cents a share, calls for a 3.2% decline co ...

Core Viewpoint - Ross Stores, Inc. is anticipated to experience revenue growth while facing a decline in earnings per share for the first quarter of fiscal 2025, with earnings estimated at $1.43 per share, a decrease of 2.1% from the previous year [1][2]. Revenue and Earnings Estimates - The consensus estimate for quarterly revenues is $4.97 billion, reflecting a growth of 2.3% compared to the same quarter last year [2]. - The company has a trailing four-quarter earnings surprise average of 7.7%, with the last reported quarter showing an earnings surprise of 8.5% [2]. Earnings Prediction Model - The earnings prediction model indicates a likely earnings beat for Ross Stores, supported by a positive Earnings ESP of +1.27% and a Zacks Rank of 3 [3]. Factors Influencing Q1 Results - Strong growth across merchandise categories and positive customer responses are expected to bolster performance, particularly appealing to price-conscious consumers [4]. - The off-price retail model and micro-merchandising strategy are anticipated to attract value-focused shoppers and optimize inventory allocation [5]. Store Expansion and Market Conditions - Consistent execution of store expansion plans is expected to contribute to top-line growth, with new store contributions reflected in the upcoming results [6]. - The company remains cautious about macroeconomic uncertainties and inflation affecting consumer spending on essentials [6]. Sales and Margin Expectations - For Q1 fiscal 2025, Ross Stores anticipates comparable store sales (comps) to decline between 3% and flat, with total sales projected to decrease by 1% to increase by 3% year-over-year [7]. - Operating margin is expected to be in the range of 11.4% to 12.1%, down from 12.2% last year, with a projected operating margin of 11.7% for the quarter [7][8]. Valuation and Stock Performance - Ross Stores is trading at a forward 12-month price-to-earnings ratio of 23.13x, which is lower than the industry average of 32.49x [9]. - The stock has gained 9.5% over the past three months, outperforming the industry growth of 3.8% [10].

Core Viewpoint - ZTO Express is set to report its first-quarter 2025 results on May 20, with earnings expected to be flat at 47 cents per share and revenues projected to rise by 21% year over year to $1.67 billion [1] Group 1: Earnings Expectations - High operating expenses are anticipated to negatively impact the company's bottom-line performance, although top-line growth is expected to be driven by strong parcel volumes [2] - ZTO Express has updated its 2025 parcel volume guidance to a range of 40.8 billion to 42.2 billion, reflecting a year-over-year increase of 20-24% [3] - The ongoing trade war between the United States and China is expected to influence the results for the upcoming quarter [3][4] Group 2: Previous Performance - In the fourth quarter of 2024, ZTO Express reported mixed results, with earnings of 44 cents per share falling short of the Zacks Consensus Estimate of 46 cents, while total revenues of $1.77 billion exceeded the estimate of $1.65 billion [7]

Core Viewpoint - Medtronic is facing challenges in the fiscal fourth quarter of 2025 due to rising costs, geopolitical pressures, and declining earnings estimates despite previous earnings beats [3][4][6]. Financial Performance - Medtronic's adjusted earnings for the last reported quarter were $1.39, exceeding the Zacks Consensus Estimate by 2.21% [1] - The Zacks Consensus Estimate for fiscal fourth-quarter revenues is $8.81 billion, indicating a year-over-year growth of 2.6% [2] - The consensus estimate for fourth-quarter earnings is $1.58 per share, reflecting an 8.2% rise year-over-year [2] - Earnings estimates for the fourth quarter have declined by 1.9% over the past 90 days [2] Challenges and Headwinds - Rising costs and expenses due to inflation and geopolitical pressures are impacting profitability [3] - The tariff environment is affecting financial outlook, particularly due to Medtronic's manufacturing presence in Mexico and Canada [4] - Lower procedural volumes in elective surgeries and other medical procedures are putting pressure on the bottom line [6] - Unfavorable currency movements are expected to negatively impact revenues by $125 million to $175 million in the fourth quarter [8] Growth Opportunities - Despite challenges, Medtronic has shown resilience with mid-single-digit organic revenue growth [9] - Key growth areas include pulse field ablation, TAVR, neuromodulation, and diabetes businesses, driven by new product launches [10][12][13] - The company has made foundational changes to improve operations and is focusing on fast-growth MedTech markets [15][16] Market Position - Medtronic's stock has declined 5.9% in the fiscal fourth quarter, underperforming compared to industry peers [20] - The company's shares trade at a Price/Earnings ratio of 14.24X, below the industry average of 21.71X and the S&P 500's 20.43X [24][25] Conclusion - Medtronic has significant long-term growth potential but faces macroeconomic headwinds and rising expenses that could impact bottom-line growth [26]

Core Viewpoint - Louisiana-Pacific Corporation (LPX) reported better-than-expected first-quarter 2025 results, with adjusted earnings and net sales surpassing the Zacks Consensus Estimate, although the bottom line declined year-over-year while the top line remained flat [1][4]. Financial Performance - Adjusted earnings per share (EPS) were $1.27, exceeding the Zacks Consensus Estimate of $1.13 by 12.4%, down from $1.53 in the prior year [4]. - Net sales reached $724 million, surpassing the consensus mark of $693 million by 4.5%, remaining flat year-over-year [4]. - Adjusted EBITDA was $162 million, down 11% from the prior-year quarter, primarily due to lower OSB selling prices and volumes, partially offset by higher Siding net sales [5]. Segment Analysis - **Siding Segment**: Sales increased 11% year-over-year to $402 million, driven by a 9% rise in volume and a 2% increase in average selling prices. Adjusted EBITDA for this segment was $106 million, up 17% from the previous year [6][7]. - **OSB Segment**: Sales decreased 15% year-over-year to $267 million, with a $32 million drop in selling prices and a $13 million decline in sales volumes. Adjusted EBITDA fell 40% year-over-year to $54 million [8]. - **LP South America (LPSA)**: Sales grew 11% year-over-year to $52 million, with adjusted EBITDA increasing 22% to $12 million, largely due to higher sales volumes despite unfavorable currency fluctuations [9]. Cash Flow and Balance Sheet - As of March 31, 2025, the company had $1 billion in liquidity, with cash and cash equivalents at $256 million, down from $340 million at the end of 2024. Long-term debt remained flat at $348 million [10]. - Net cash provided by operations was $64 million compared to $105 million in the same period last year [10]. - The company repurchased 0.6 million shares for $61 million during the first quarter, with $177 million remaining under share repurchase authorizations [11]. Future Outlook - For Q2 2025, LPX expects Siding net sales to range between $445 million and $455 million, reflecting 9-11% growth year-over-year, with adjusted EBITDA between $110 million and $120 million [12]. - For the full year, Siding's net sales are anticipated to grow over 9%, reaching approximately $1.7 billion, with adjusted EBITDA expected between $425 and $435 million [14]. - Consolidated adjusted EBITDA is now projected to be between $535 million and $555 million, down from previous expectations [15].

Occidental Petroleum (OXY) is expected to report a year-over-year increase in its top and bottom lines when it reports first-quarter 2025 results on May 7, after market close. (See the Zacks Earnings Calendar to stay ahead of market-making news.)The Zacks Consensus Estimate for OXY’s first-quarter revenues is pegged at $7.15 billion, indicating an increase of 18.93% from the year-ago reported figure.The Zacks Consensus Estimate for earnings is pegged at 73 cents per share. The Zacks Consensus Estimate for O ...

Core Viewpoint - ANI Pharmaceuticals is expected to exceed expectations in its first-quarter 2025 results, with revenue estimates at $179.5 million and earnings at $1.37 per share [1] Group 1: Revenue Drivers - The company's revenue growth is primarily driven by sales of rare disease products, particularly Cortrophin Gel, which has seen increased demand from new patient starts [3][4] - Additional revenue contributions are anticipated from newly acquired products Iluvien and Yutiq, which were added to the portfolio after the acquisition of Alimera Sciences [4] - The Zacks Consensus Estimate for revenues from the rare disease and brands business is $87 million, while revenues from generic and other segments are estimated at $105 million, driven by newly launched products [5][6] Group 2: Operating Expenses - Increased spending on research and development due to ongoing and new projects is likely to have raised operating expenses in the first quarter [7] Group 3: Earnings Performance - ANI Pharmaceuticals has a strong history of earnings surprises, having beaten earnings estimates in each of the last four quarters with an average surprise of 17.32% [8] - The company has an Earnings ESP of +0.86%, indicating a favorable outlook for an earnings beat [9] - Currently, ANI Pharmaceuticals holds a Zacks Rank of 2 (Buy), suggesting positive market sentiment [10]

Core Viewpoint - Molson Coors Beverage Company (TAP) is anticipated to report declines in both revenue and earnings for the first quarter of 2025, with revenues expected at $2.4 billion, reflecting a 6% decrease year-over-year, and earnings per share projected at 80 cents, down 15.8% from the previous year [1] Financial Performance - In the last reported quarter, Molson Coors achieved an earnings surprise of 15%, with an average earnings surprise of 18.1% over the trailing four quarters [2] - The Zacks Model indicates a potential earnings beat for TAP, supported by a Zacks Rank of 3 (Hold) and an Earnings ESP of +4.01% [3] Market Trends and Growth Drivers - TAP has shown strong brand resilience, particularly in the U.S. market, with core brands like Coors Light and Miller Lite performing well, and Coors Banquet experiencing notable volume growth [4] - The company's Acceleration Plan has facilitated market share gains through innovation and premiumization, with strategic investments in core brands contributing to top-line growth [5] - Enhanced digital capabilities and expansion of brewing and packaging operations in the U.K. have been driven by the success of the Madri brand [6] - Strong performance in the EMEA and APAC segments, along with growth in Canada, has been supported by favorable net pricing and higher brand volumes [7] Challenges and Cost Pressures - The company faces challenges from inflationary pressures on raw materials and manufacturing costs, as well as an unfavorable product mix, which management has indicated will impact costs of goods sold (COGS) [8] - The evolving global macroeconomic environment, including geopolitical tensions and trade policy shifts, creates uncertainty that may affect consumer behavior and financial performance [9] - One-time transition and integration costs related to the partnership with Fever-Tree are expected to impact underlying financials for the first quarter [10] Valuation Perspective - Molson Coors is currently trading at a forward 12-month price-to-earnings ratio of 8.87X, which is below its five-year high of 15.57X and the industry average of 16.25X, indicating an attractive investment opportunity [12] - Over the past three months, TAP shares have increased by 5.9%, compared to the industry's growth of 17.4% [13]

Core Viewpoint - Fidelity National Information Services, Inc. (FIS) is expected to report first-quarter 2025 results on May 6, 2025, with earnings estimated at $1.20 per share and revenues at $2.5 billion, indicating a year-over-year earnings increase of 9.1% and revenue growth of 1.7% [1][2] Financial Performance Estimates - The Zacks Consensus Estimate for FIS's 2025 revenues is $10.5 billion, reflecting a year-over-year rise of 3.4%, while the EPS for the current year is estimated at $5.74, indicating a growth of approximately 10% year-over-year [2] - FIS has consistently beaten consensus estimates in the last four quarters, with an average surprise of negative 9.4% [2] Earnings Prediction - The company is predicted to likely beat earnings this quarter, supported by a positive Earnings ESP of +0.76% and a Zacks Rank of 2 (Buy) [3] Revenue Breakdown - The consensus estimate for Banking Solutions revenues indicates a 1.3% year-over-year increase, while Capital Market Solutions is expected to see a revenue increase of around 7% compared to the same quarter last year [5] - Total Recurring revenues are projected to grow by approximately 1%, with North America and All Other revenues expected to grow by 1% and 2% year-over-year, respectively [6][7] EBITDA Estimates - The adjusted EBITDA for Capital Market Solutions is estimated to increase by 7.5% year-over-year, while total operating expenses are expected to decline by 2.8% year-over-year [7] - The company anticipates adjusted EBITDA to be in the range of $940-$960 million, with an adjusted EBITDA margin projected between 37.8-38.2% [9] Challenges - The adjusted EBITDA for Banking Solutions is expected to decline by 2.5% year-over-year, which may offset some positive growth factors [8]

Core Insights - Emerson Electric Co. (EMR) is expected to report growth in both revenue and earnings for the second quarter of fiscal 2025, with revenue estimated at $4.38 billion, reflecting a 0.1% increase year-over-year, and earnings per share projected at $1.42, a 4.4% rise from the previous year [1][3]. Group 1: Performance Expectations - The Intelligent Devices segment is anticipated to see a slight revenue decrease of 0.1% to $3.06 billion, influenced by strong performance in the final control business and solid momentum in power end markets [3][4]. - The Software and Control segment is expected to grow by 0.6% year-over-year to $1.34 billion, driven by robust growth in the Control Systems & Software business and increased license revenues from AspenTech [5]. Group 2: Recent Acquisitions - The acquisition of Afag and Flexim in Q4 of fiscal 2023 has enhanced Emerson's capabilities in factory automation and flow measurement, expanding its reach into high-demand markets such as battery manufacturing and automotive [6]. - The recent acquisition of National Instruments in October 2023 is likely to further strengthen Emerson's position in high-growth sectors, including semiconductors and electric vehicles [7]. Group 3: Cost and Margin Considerations - Rising costs associated with acquisitions and restructuring efforts may negatively impact EMR's margin performance, alongside potential foreign currency headwinds affecting profitability [8]. Group 4: Earnings Predictions - The company has a positive Earnings ESP of +2.42%, with the most accurate estimate at $1.45 per share, suggesting a strong likelihood of an earnings beat [10].